Additionally, they aimed to predict the impact of activating PPARα by lipids and showed that PPARα activation appears to have a significant role in hepatic steatosis progression, suggesting issues with PPARα agonists as treatment options [97]. This evidence concerns the gene PPARA and Hepatic steatosis.